Literature DB >> 19772701

Quitting smoking during early versus late pregnancy: the risk of preeclampsia and adverse birth outcomes.

Xu Xiong1, Jun Zhang2, William D Fraser3.   

Abstract

OBJECTIVE: To examine the impact of women's quitting smoking during early and late pregnancy on their risk of preeclampsia and on birth outcomes.
METHODS: We analyzed data from a case-control study of 86 preeclamptic women and 239 controls at three hospitals in Quebec between January 2003 and March 2006.
RESULTS: Compared with never having smoked, early smoking cessation, i.e., quitting before 20 weeks' gestation, was not associated with a reduced risk of preeclampsia (adjusted OR 1.03; 95% CI 0.42-2.60). Both late smoking cessation (quitting after 20 weeks of gestation) and persistent smoking (smoking before and during pregnancy) were associated with a non-significant reduction in the risk of preeclampsia (aOR 0.78; 95% CI 0.12-5.02 for late quitting and aOR 0.62; 95% CI 0.16-2.37 for persistent smoking). However, persistent smoking was associated with an increased risk of other adverse pregnancy outcomes, such as low birth weight (aOR 10.2; 95% CI 2.49-41.8) and preterm birth (aOR 3.59; 95% CI 1.06-12.1).
CONCLUSION: Although late quitting and persistent smoking may be associated with a decreased risk of preeclampsia, the benefit of early smoking cessation on pregnancy outcome is evident.

Entities:  

Mesh:

Year:  2009        PMID: 19772701     DOI: 10.1016/S1701-2163(16)34273-6

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  2 in total

1.  Maternal active and passive smoking and hypertensive disorders of pregnancy: risk with trimester-specific exposures.

Authors:  Stephanie M Engel; Erica Scher; Sylvan Wallenstein; David A Savitz; Elin R Alsaker; Lill Trogstad; Per Magnus
Journal:  Epidemiology       Date:  2013-05       Impact factor: 4.822

2.  First-trimester smoking cessation in pregnancy did not increase the risk of preeclampsia/eclampsia: A Murmansk County Birth Registry study.

Authors:  Olga A Kharkova; Andrej M Grjibovski; Alexandra Krettek; Evert Nieboer; Jon Ø Odland
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.